Valuation: Uniphar plc

Capitalization 1.09B 1.28B 1B 949M 1.76B 123B 1.77B 11.94B 4.65B 58.17B 4.81B 4.71B 202B P/E ratio 2026 *
18.9x
P/E ratio 2027 * 15.9x
Enterprise value 1.4B 1.64B 1.28B 1.21B 2.25B 157B 2.27B 15.27B 5.94B 74.39B 6.15B 6.02B 258B EV / Sales 2026 *
0.44x
EV / Sales 2027 * 0.4x
Free-Float
94.91%
Yield 2026 *
0.5%
Yield 2027 * 0.51%
1 day+0.95%
1 week-1.96%
Current month+2.16%
1 month+9.96%
3 months+7.32%
6 months+8.97%
Current year+20.74%
1 week 4.15
Extreme 4.15
4.35
1 month 3.88
Extreme 3.88
4.35
Current year 3.43
Extreme 3.43
4.35
1 year 3.24
Extreme 3.245
4.35
3 years 1.9
Extreme 1.904
4.35
5 years 1.9
Extreme 1.904
5.08
10 years 0.96
Extreme 0.965
5.08
Manager TitleAgeSince
Chief Executive Officer - 2010-02-28
Director of Finance/CFO 62 2010-06-30
Chief Tech/Sci/R&D Officer 58 2025-01-20
Director TitleAgeSince
Chairman - 2008-12-31
Director/Board Member - 2010-02-28
Director/Board Member 62 2010-06-30
Change 5d. change 1-year change 3-years change Capi.($)
+0.95%-1.96%+26.88%+33.02% 1.28B
+1.31%-8.28%+6.86%+88.40% 88.31B
+0.03%-7.33%+22.84%+115.36% 42.76B
+0.35%-2.05%-5.61%+308.57% 23.66B
+0.39%+0.63%-10.89%-16.81% 8.67B
0.00%+0.35%-5.87%-22.15% 8.47B
-0.92%-2.14%-0.71%-31.50% 7.36B
+0.43%-1.97%+36.61%+11.49% 6.28B
-1.48%-0.49%-2.62%+7.35% 5.29B
+0.60%-1.93%-2.87%-12.38% 3.72B
Average -0.03%-1.95%+6.46%+48.14% 19.58B
Weighted average by Cap. -0.29%-5.68%+7.87%+100.02%

Financials

2026 *2027 *
Net sales 3.21B 3.76B 2.94B 2.79B 5.16B 360B 5.21B 35.05B 13.65B 171B 14.12B 13.82B 593B 3.36B 3.94B 3.08B 2.92B 5.41B 377B 5.46B 36.74B 14.31B 179B 14.8B 14.49B 622B
Net income 52.42M 61.46M 48.07M 45.5M 84.33M 5.88B 85.14M 573M 223M 2.79B 231M 226M 9.69B 66.4M 77.85M 60.89M 57.64M 107M 7.45B 108M 725M 282M 3.53B 292M 286M 12.28B
Net Debt 305M 357M 279M 265M 490M 34.2B 495M 3.33B 1.3B 16.22B 1.34B 1.31B 56.36B 250M 293M 230M 217M 403M 28.09B 407M 2.73B 1.06B 13.32B 1.1B 1.08B 46.3B
Logo Uniphar plc
Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions - Uniphar Pharma, Uniphar Medtech and Uniphar Supply Chain & Retail. With a workforce of more than 3,500, the Group is active in Europe, North America, Asia/Pacific and the Middle East and North Africa region, and delivers more than 160 countries. The Group's vision is to improve patient access to pharmaco-medical products and treatments by enhancing connectivity between manufacturers and healthcare stakeholders. Uniphar plc represents a strong combination of scale, growth and profitability.
Employees
3,500
Date Price Change Volume
26-05-13 4.250 +0.95% 304,545
26-05-12 4.210 -2.09% 455,460
26-05-11 4.300 +0.12% 287,236
26-05-08 4.295 -0.12% 313,686
26-05-07 4.300 -0.81% 263,805
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
4.210EUR
Average target price
5.338EUR
Spread / Average Target
+26.78%

Quarterly revenue - Rate of surprise